Search Results 291-300 of 16992 for pharmacogenetics
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The goal of this proposed study is to examine the genetic signature of the validated proteomic signature (model) based on a panel of serum proteomic markers ...
List of GME residency and fellowship training programs in medical genetics and genomics at Mayo Clinic School of Graduate Medical Education.
Kirk J. Wangensteen, M.D., Ph.D., engages in research collaborations with other Mayo Clinic investigators.
Mayo Clinic's Department of Molecular Medicine provides resources in toxicology and pharmacology, noninvasive optical imaging, and gene and virus therapy.
The Copland Cancer Biology and Translational Research Lab at Mayo Clinic is studying novel genetic targets for specific subtypes of cancer.
About this study. The purpose of this study is to use whole genome sequencing to identify more causal pathways and variants responsible for hereditary ...
Cholangiocarcinoma (CCA) is an aggressive cancer that forms in the cells that line the bile duct. The only treatment options include aggressive chemotherapy ...
Karter's journey of hope · Science Saturday: Potential new treatment for breast cancer metastasis featured image · Immune response to ovarian cancer may predict ...
Adedinsewo D, Dugan J, Johnson PW, Douglass EJ, Morales-Lara AC, Parkulo MA, Ting HH, Cooper LT, Scott LR, Valverde AM, Padmanabhan D, Peters NS, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.